Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status.

[1]  J. Fostel,et al.  Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice. , 2012, Antioxidants & redox signaling.

[2]  B. Solomon,et al.  Inhibition of DNA-Dependent Protein Kinase Induces Accelerated Senescence in Irradiated Human Cancer Cells , 2011, Molecular Cancer Research.

[3]  W. Mitzner,et al.  Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice. , 2011, American journal of respiratory cell and molecular biology.

[4]  Clyde J. Wright,et al.  Targeting Inflammation to Prevent Bronchopulmonary Dysplasia: Can New Insights Be Translated Into Therapies? , 2011, Pediatrics.

[5]  M. O’Reilly,et al.  Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice. , 2011, The American journal of pathology.

[6]  Yang Yu,et al.  Hyperoxia Impairs Alveolar Formation and Induces Senescence Through Decreased Histone Deacetylase Activity and Up-Regulation of p21 in Neonatal Mouse Lung , 2011, Pediatric Research.

[7]  W. Tarnow-Mordi,et al.  Increased 36 week survival with high oxygen saturation target in extremely preterm infants , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[8]  L. Yarmus,et al.  Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model , 2011, Science Translational Medicine.

[9]  D. Aune,et al.  In Search of the Optimal Oxygen Saturation for Extremely Low Birth Weight Infants: A Systematic Review and Meta-Analysis , 2010, Neonatology.

[10]  K. Chung,et al.  TGF-β regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells , 2010, American journal of physiology. Lung cellular and molecular physiology.

[11]  Yusuke Nakamura,et al.  Crosstalk of EDA-A2/XEDAR in the p53 Signaling Pathway , 2010, Molecular Cancer Research.

[12]  G. Baumann,et al.  Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. , 2009, Free radical biology & medicine.

[13]  B. Murphy,et al.  Pathogenesis of Bronchopulmonary Dysplasia , 2009, Respiration.

[14]  S. Biswal,et al.  Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[15]  A. Dinkova-Kostova,et al.  Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex , 2007, Proceedings of the National Academy of Sciences.

[16]  R. Homer,et al.  Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[17]  B. Thébaud,et al.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. , 2007, American journal of respiratory and critical care medicine.

[18]  M. Sporn,et al.  Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. , 2006, Biochemical and biophysical research communications.

[19]  L. Brion,et al.  Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. , 2006, The Cochrane database of systematic reviews.

[20]  V. Fellman,et al.  N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial. , 2003, The Journal of pediatrics.

[21]  G. Vardon,et al.  Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. , 2003, Chest.

[22]  T. Ahmed,et al.  Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. , 2002, International journal of oncology.

[23]  M. O’Reilly,et al.  Accumulation of p21Cip1/WAF1 during Hyperoxic Lung Injury in Mice , 1998 .

[24]  J. Wispé,et al.  Functional and pathological effects of prolonged hyperoxia in neonatal mice. , 1998, American Journal of Physiology.

[25]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[26]  S. Corroyer,et al.  Altered Regulation of G1 Cyclins in Oxidant-induced Growth Arrest of Lung Alveolar Epithelial Cells , 1996, The Journal of Biological Chemistry.

[27]  J. Hasday,et al.  Increased Activity of Interleukin-6 but not Tumor Necrosis Factor-α in Lung Lavage of Premature Infants is Associated with the Development of Bronchopulmonaiy Dysplasia , 1994, Pediatric Research.

[28]  S. McGrath.  Induction of p21WAF/CIP1 during hyperoxia. , 1998, American journal of respiratory cell and molecular biology.

[29]  M. O’Reilly,et al.  Accumulation of p21(Cip1/WAF1) during hyperoxic lung injury in mice. , 1998, American journal of respiratory cell and molecular biology.

[30]  M. Kastan,et al.  p53 and ATM: cell cycle, cell death, and cancer. , 1997, Advances in cancer research.